fullerene c60 has been researched along with HIV Coinfection in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, L; Leszczynska, D; Leszczynski, J; Rasulev, B; Turabekova, M | 1 |
| Lin, CM; Lu, TY | 1 |
| Abdelnabi, R; Boonen, A; Camarasa, MJ; Gago, F; Illescas, BM; Martí-Marí, O; Martín, N; Mills, A; Neyts, J; Noppen, S; Ruiz-Santaquiteria, M; San-Félix, A; Schols, D | 1 |
| Liu, Z; Pang, X; Zhai, G | 1 |
| Anilkumar, P; Cao, L; Liu, JH; Lu, F; Luo, PG; Sahu, S; Sun, YP; Tackett, KN; Wang, Y | 1 |
| Kudo, E; Matsumura, S; Okada, S; Sakai, S; Takahashi, D; Tanimoto, S; Toshima, K | 1 |
1 review(s) available for fullerene c60 and HIV Coinfection
| Article | Year |
|---|---|
Advances in non-peptidomimetic HIV protease inhibitors.
Topics: Drug Design; Drug Resistance, Viral; Fullerenes; HIV; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Organometallic Compounds; Pyrones; Pyrrolidines; Sulfonamides; Urea | 2014 |
5 other study(ies) available for fullerene c60 and HIV Coinfection
| Article | Year |
|---|---|
Receptor- and ligand-based study of fullerene analogues: comprehensive computational approach including quantum-chemical, QSAR and molecular docking simulations.
Topics: Fullerenes; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Molecular Docking Simulation; Quantitative Structure-Activity Relationship | 2013 |
C60 fullerene derivatized nanoparticles and their application to therapeutics.
Topics: Antiviral Agents; Blood-Brain Barrier; Drug Carriers; Fullerenes; HIV Infections; Humans; Nanomedicine; Nanoparticles; Nanotechnology; Neurodegenerative Diseases; Pharmaceutical Preparations; Photochemotherapy | 2012 |
Multivalent Tryptophan- and Tyrosine-Containing [60]Fullerene Hexa-Adducts as Dual HIV and Enterovirus A71 Entry Inhibitors.
Topics: Enterovirus; Fullerenes; Hexosaminidase A; HIV Infections; Humans; Tryptophan; Tyrosine | 2021 |
Fullerenes for applications in biology and medicine.
Topics: Animals; Anti-HIV Agents; Contrast Media; Drug Carriers; Free Radical Scavengers; Fullerenes; HIV; HIV Infections; Humans; Magnetic Resonance Imaging; Melanoma; Models, Molecular; Nanomedicine; Nanostructures; Photochemotherapy; Photosensitizing Agents | 2011 |
Target-selective photodegradation of HIV-1 protease and inhibition of HIV-1 replication in living cells by designed fullerene-sugar hybrids.
Topics: Carbohydrates; Cell Line; Fullerenes; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Leukocytes, Mononuclear; Light; Models, Molecular; Photolysis; T-Lymphocytes; Ultraviolet Rays | 2012 |